Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6155363 | 0.92 | ALDH1A1 (0.34) | ALDH1A1L3MBTL1DGKAKDM4EDUSP3 | |
| SCHEMBL4286159 | 0.91 | NAAA (0.39) | ALDH1A1L3MBTL1DGKAKDM4EDUSP3 | |
| SCHEMBL29980213 | 0.87 | MGAM (0.38) | ALDH1A1L3MBTL1MEN1KMT2APOLB | |
| SCHEMBL8798167 | 0.82 | NAAA (0.42) | ALDH1A1L3MBTL1DGKAKDM4EDUSP3 | |
| SCHEMBL6155660 | 0.82 | NAAA (0.42) | ALDH1A1L3MBTL1DGKAKDM4EDUSP3 | |
| SCHEMBL8155173 | 0.81 | TSHR (0.33) | ALDH1A1L3MBTL1DGKAKDM4EDUSP3 | |
| SCHEMBL10087479 | 0.80 | TSHR (0.33) | MEN1KMT2AHSD17B10 | |
| SCHEMBL6155107 | 0.78 | NAAA (0.40) | ALDH1A1L3MBTL1DGKAKDM4EDUSP3 | |
| SCHEMBL395418 | 0.78 | MGAM (0.41) | ALDH1A1KDM4EMEN1KMT2ALMNA | |
| SCHEMBL391523 | 0.78 | MGAM (0.41) | ALDH1A1KDM4EMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6962994-B2 | Process for the synthesis of 1,3-diols | WARNER-LAMBERT COMPANY, LLC (US) | 2005-11-08 | — | — | US | disclosed |
| US-20040006231-A1 | Process for the synthesis of 1,3-diols | BOSCH ROBERT LEE (US) | 2004-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006231-A1 | Process for the synthesis of 1,3-diols | HSD17B7, HSD11B1, BCKDK | ALDH1A1 307/4885L3MBTL1 2123/4885DGKA 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.